Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02459301
Title Dose-Ranging Study of IPH2201 in Patients With High Grade Serious CA of Ovarian, Fallopian Tube or Peritoneal Origin
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

Therapies

Monalizumab

Age Groups: adult
Covered Countries CAN


No variant requirements are available.